Literature DB >> 10827156

Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid.

M Axelson1, E Ellis, B Mörk, K Garmark, A Abrahamsson, I Björkhem, B G Ericzon, C Einarsson.   

Abstract

The biosynthesis of bile acids by primary cultures of normal human hepatocytes has been investigated. A general and sensitive method for the isolation and analysis of sterols and bile acids was used, based on anion exchange chromatography and gas chromatography-mass spectrometry (GC/MS). Following incubation for 5 days, 8 oxysterols and 8 C(27)- or C(24)-bile acids were identified in media and cells. Cholic and chenodeoxycholic acids conjugated with glycine or taurine were by far the major steroids found, accounting for 70% and 24% of the total, respectively, being consistent with bile acid synthesis in human liver. Small amounts of sulfated 3beta-hydroxy-5-cholenoic acid and 3beta,7alpha-dihydroxy-5beta-cholanoic acid were also detected. Nine steroids were potential bile acid precursors (2% of total), the major precursors being 7alpha, 12alpha-dihydroxy-3-oxo-4-cholenoic acid and its 5beta-reduced form. These 2 and 5 other intermediates formed a complete metabolic sequence from cholesterol to cholic acid (CA). This starts with 7alpha-hydroxylation of cholesterol, followed by oxidation to 7alpha-hydroxy-4-cholesten-3-one and 12alpha-hydroxylation. Notably, 27-hydroxylation of the product 7alpha, 12alpha-dihydroxy-4-cholesten-3-one and further oxidation and cleavage of the side chain precede A-ring reduction. A-Ring reduction may also occur before side-chain cleavage, but after 27-hydroxylation, yielding 3alpha,7alpha, 12alpha-trihydroxy-5beta-cholestanoic acid as an intermediate. The amounts of the intermediates increased in parallel to those of CA during 4 days of incubation. Suppressing 27-hydroxylation with cyclosporin A (CsA) resulted in a 10-fold accumulation of 7alpha, 12alpha-dihydroxy-4-cholesten-3-one and a decrease of the production of CA and its acidic precursors. These results suggest that the observed intermediates reflect an alternative biosynthetic pathway to CA, which may be quantitatively significant in the cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827156     DOI: 10.1053/jhep.2000.7877

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Quantification of common and planar bile acids in tissues and cultured cells.

Authors:  Stephanie J Shiffka; Jace W Jones; Linhao Li; Ann M Farese; Thomas J MacVittie; Hongbing Wang; Peter W Swaan; Maureen A Kane
Journal:  J Lipid Res       Date:  2020-07-22       Impact factor: 5.922

2.  Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts.

Authors:  Matthew D Krasowski; Kazuto Yasuda; Lee R Hagey; Erin G Schuetz
Journal:  Mol Endocrinol       Date:  2005-02-17

3.  Bile acid formation in primary human hepatocytes.

Authors:  Curt Einarsson; Ewa Ellis; Anna Abrahamsson; Bo-Goran Ericzon; Ingermar Bjorkhem; Magnus Axelson
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

4.  Addition of Dexamethasone Alters the Bile Acid Composition by Inducing CYP8B1 in Primary Cultures of Human Hepatocytes.

Authors:  Lisa-Mari Mörk; Stephen C Strom; Agneta Mode; Ewa C S Ellis
Journal:  J Clin Exp Hepatol       Date:  2016-02-10

5.  Suppression of bile acid synthesis by thyroid hormone in primary human hepatocytes.

Authors:  Ewa Cristine Siljevik Ellis
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 6.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 7.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 8.  Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.

Authors:  Wei Jia; Guoxiang Xie; Weiping Jia
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-10-11       Impact factor: 46.802

Review 9.  Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.

Authors:  Jie Cai; Lulu Sun; Frank J Gonzalez
Journal:  Cell Host Microbe       Date:  2022-03-09       Impact factor: 21.023

10.  Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture System.

Authors:  Ujjal Sarkar; Kodihalli C Ravindra; Emma Large; Carissa L Young; Dinelia Rivera-Burgos; Jiajie Yu; Murat Cirit; David J Hughes; John S Wishnok; Douglas A Lauffenburger; Linda G Griffith; Steven R Tannenbaum
Journal:  Drug Metab Dispos       Date:  2017-04-27       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.